These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9459130)

  • 1. New method for determining prognosis of patients with psoriasis (E-PAP).
    Sugai J; Ozawa A; Kawakubo Y; Iizuka M; Miyahara M; Ohkido M
    J Dermatol Sci; 1998 Jan; 16(2):165-9. PubMed ID: 9459130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.
    Ozawa A; Sugai J; Ohkido M; Ohtsuki M; Nakagawa H; Kitahara H; Tamaki K; Urabe K; Nakayama J; Horikoshi T; Morimoto Y; Jimbow K
    Eur J Dermatol; 1999; 9(3):218-23. PubMed ID: 10210789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.
    Micali G; Wilsmann-Theis D; Mallbris L; Gallo G; Marino V; Brault Y; Germain JM
    Acta Derm Venereol; 2015 Jan; 95(1):57-61. PubMed ID: 24682319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
    Ohtsuki M; Nakagawa H; Sugai J; Ozawa A; Ohkido M; Nakayama J; Hanada J; Morimoto Y; Jimbow K; Horikoshi T; Kitahara H; Tamaki K; Urabe K; Hori Y
    J Dermatol; 2003 Apr; 30(4):290-8. PubMed ID: 12707465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
    Meffert H; Bräutigam M; Färber L; Weidinger G
    Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
    Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
    J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Chow C; Simpson MJ; Luger TA; Chubb H; Ellis CN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1406-14. PubMed ID: 25917315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.
    Touw CR; Hakkaart-Van Roijen L; Verboom P; Paul C; Rutten FF; Finlay AY
    Br J Dermatol; 2001 May; 144(5):967-72. PubMed ID: 11359382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients.
    Okubo Y; Natsume S; Usui K; Amaya M; Tsuboi R
    J Dermatol; 2011 May; 38(5):465-72. PubMed ID: 21352289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
    Peluso AM; Bardazzi F; Tosti A; Varotti C
    Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
    Colombo D; Cassano N; Altomare G; Giannetti A; Vena GA
    Int J Immunopathol Pharmacol; 2010; 23(4):1143-52. PubMed ID: 21244763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
    Thaçi D; Bräutigam M; Kaufmann R; Weidinger G; Paul C; Christophers E
    Dermatology; 2002; 205(4):383-8. PubMed ID: 12444336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept of Remission in Chronic Plaque Psoriasis.
    Gisondi P; Di Mercurio M; Idolazzi L; Girolomoni G
    J Rheumatol Suppl; 2015 Nov; 93():57-60. PubMed ID: 26523059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of infliximab in the treatment of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
    Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
    Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
    Reich K; Sinclair R; Roberts G; Griffiths CE; Tabberer M; Barker J
    Curr Med Res Opin; 2008 May; 24(5):1237-54. PubMed ID: 18355421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.
    Hashimoto T; Kawakami T; Tsuruta D; Hamada T; Natsuaki Y; Fukuda S; Koga H; Sogame R; Ohyama B; Ono F; Karashima T; Nakama T; Dainichi T; Ishii N; Yasumoto S
    Australas J Dermatol; 2012 Aug; 53(3):202-6. PubMed ID: 22881466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
    Shintani Y; Kaneko N; Furuhashi T; Saito C; Morita A
    J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.